Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Colorectal Cancer
Interventions
DRUG

ABX-EGF

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY